MOONLAKE IMMUNOTHERAPEUTICS Stock Issued During Period, Shares, Conversion of Convertible Securities
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) reported Stock Issued During Period, Shares, Conversion of Convertible Securities of 19.21 million shares for the 10-month period ending 2021-12-31, per its 10-K filed 2023-03-20.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2023-03-20
- 2021-12-31: Stock Issued During Period, Shares, Conversion of Convertible Securities 10 month 19.21M shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities 10 month |
|---|---|
| 2021-12-31 | 19.21M shares 10-K · filed 2023-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |